The Vertex Pharmaceuticals Incorporated (VRTX) ROIC is (16.5%), compared to the industry median of ((125.1%)) and the 5-year historical average of 52.7%.
The Vertex Pharmaceuticals Incorporated (VRTX) ROIC minus WACC is (23.4%), compared to the industry median of ((131.8%)) and the 5-year historical average of 46.9%.
The Vertex Pharmaceuticals Incorporated (VRTX) ROE is (3.2%), compared to the industry median of ((52.2%)) and the 5-year historical average of 22.4%.
The Vertex Pharmaceuticals Incorporated (VRTX) ROCE is (6.0%), compared to the industry median of ((51.2%)) and the 5-year historical average of 18.2%.